TMCR · Metals Royalty Co Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-13 | Hess Michael Bernard |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option shall vest and become exercisable in four equal annual installments commencing from July 13, 2026, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Stock Option (right to buy)
|
1,000,000 |
| 2026-07-13 | Hess Michael Bernard |
Director |
Award↑
Filing footnotes — Common Shares (Direct)
Includes 1,000,000 performance share units subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Common Shares
|
2,000,000 |
| 2026-06-01 | O'Neill Brian Thomas |
Director |
Award↑
Filing footnotes — Common Shares (Direct)
Represents shares purchased by the Reporting Person directly from the Issuer in a private placement, which purchase is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). |
Common Shares
|
10,000 |
| 2026-06-01 | Sewell Donald Richard |
President & CFO |
Award↑
Filing footnotes — Common Shares (Direct)
Represents shares purchased by the Reporting Person directly from the Issuer in a private placement, which purchase is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended. |
Common Shares
|
3,847 |
| 2026-06-01 | Paes-Braga Brian |
Director, Chairman & CEO, 10% Owner |
Award↑
Filing footnotes — Common Shares (Direct)
Represents shares purchased by the Reporting Person directly from the Issuer in a private placement, which purchase is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended. |
Common Shares
|
200,000 |